A Treatment Option for Mild-to-Moderate Atopic Dermatitis in Patients Aged 3 Months and Older

Join us for an interactive presentation on a steroid-free topical therapy for the treatment of mild-to-moderate atopic dermatitis. Expert faculty will guide the audience through an in-depth look into the product and answer questions to help attendees gain a better understanding of this treatment option.

Presented by: Pfizer